0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single-target MET TKIs Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-28D17889
Home | Market Reports | Health| Health Conditions| Cancer
Global Single target MET TKIs Market Research Report 2024
BUY CHAPTERS

Global Single-target MET TKIs Market Research Report 2024

Code: QYRE-Auto-28D17889
Report
August 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Single-target MET TKIs Market

Single-target MET tyrosine kinase inhibitors (TKIs) are drugs specifically designed to block the activity of the MET receptor tyrosine kinase alone, focusing on disrupting the MET signaling pathway that promotes cancer cell growth, survival, and metastasis.
The global Single-target MET TKIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Single-target MET TKIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single-target MET TKIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Single-target MET TKIs include Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Single-target MET TKIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-target MET TKIs.
The Single-target MET TKIs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Single-target MET TKIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-target MET TKIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Single-target MET TKIs Market Report

Report Metric Details
Report Name Single-target MET TKIs Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Single-target MET TKIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Single-target MET TKIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Single-target MET TKIs Market report?

Ans: The main players in the Single-target MET TKIs Market are Novartis, Merck, WuXi STA, Shanghai Hutchison Pharmaceuticals, Haihe Biopharma, CSPC Pharmaceutical, Avistone Pharmaceuticals Biotechnology, Asymchem

What are the Application segmentation covered in the Single-target MET TKIs Market report?

Ans: The Applications covered in the Single-target MET TKIs Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Single-target MET TKIs Market report?

Ans: The Types covered in the Single-target MET TKIs Market report are Capmatinib, Tepotinib, Savolitinib, Glumetinib, Vebreltinib, Other

Recommended Reports

Tyrosine Kinase Inhibitors

Targeted Cancer Therapies

Hematological Malignancy Treatments

1 Single-target MET TKIs Market Overview
1.1 Product Definition
1.2 Single-target MET TKIs by Type
1.2.1 Global Single-target MET TKIs Market Value Comparison by Type (2024-2030)
1.2.2 Capmatinib
1.2.3 Tepotinib
1.2.4 Savolitinib
1.2.5 Glumetinib
1.2.6 Vebreltinib
1.2.7 Other
1.3 Single-target MET TKIs by Application
1.3.1 Global Single-target MET TKIs Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Single-target MET TKIs Market Size Estimates and Forecasts
1.4.1 Global Single-target MET TKIs Revenue 2019-2030
1.4.2 Global Single-target MET TKIs Sales 2019-2030
1.4.3 Global Single-target MET TKIs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Single-target MET TKIs Market Competition by Manufacturers
2.1 Global Single-target MET TKIs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Single-target MET TKIs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Single-target MET TKIs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Single-target MET TKIs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Single-target MET TKIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Single-target MET TKIs, Product Type & Application
2.7 Global Key Manufacturers of Single-target MET TKIs, Date of Enter into This Industry
2.8 Global Single-target MET TKIs Market Competitive Situation and Trends
2.8.1 Global Single-target MET TKIs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Single-target MET TKIs Players Market Share by Revenue
2.8.3 Global Single-target MET TKIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Single-target MET TKIs Market Scenario by Region
3.1 Global Single-target MET TKIs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Single-target MET TKIs Sales by Region: 2019-2030
3.2.1 Global Single-target MET TKIs Sales by Region: 2019-2024
3.2.2 Global Single-target MET TKIs Sales by Region: 2025-2030
3.3 Global Single-target MET TKIs Revenue by Region: 2019-2030
3.3.1 Global Single-target MET TKIs Revenue by Region: 2019-2024
3.3.2 Global Single-target MET TKIs Revenue by Region: 2025-2030
3.4 North America Single-target MET TKIs Market Facts & Figures by Country
3.4.1 North America Single-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Single-target MET TKIs Sales by Country (2019-2030)
3.4.3 North America Single-target MET TKIs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Single-target MET TKIs Market Facts & Figures by Country
3.5.1 Europe Single-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Single-target MET TKIs Sales by Country (2019-2030)
3.5.3 Europe Single-target MET TKIs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Single-target MET TKIs Market Facts & Figures by Region
3.6.1 Asia Pacific Single-target MET TKIs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Single-target MET TKIs Sales by Region (2019-2030)
3.6.3 Asia Pacific Single-target MET TKIs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Single-target MET TKIs Market Facts & Figures by Country
3.7.1 Latin America Single-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Single-target MET TKIs Sales by Country (2019-2030)
3.7.3 Latin America Single-target MET TKIs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Single-target MET TKIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Single-target MET TKIs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Single-target MET TKIs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Single-target MET TKIs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Single-target MET TKIs Sales by Type (2019-2030)
4.1.1 Global Single-target MET TKIs Sales by Type (2019-2024)
4.1.2 Global Single-target MET TKIs Sales by Type (2025-2030)
4.1.3 Global Single-target MET TKIs Sales Market Share by Type (2019-2030)
4.2 Global Single-target MET TKIs Revenue by Type (2019-2030)
4.2.1 Global Single-target MET TKIs Revenue by Type (2019-2024)
4.2.2 Global Single-target MET TKIs Revenue by Type (2025-2030)
4.2.3 Global Single-target MET TKIs Revenue Market Share by Type (2019-2030)
4.3 Global Single-target MET TKIs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Single-target MET TKIs Sales by Application (2019-2030)
5.1.1 Global Single-target MET TKIs Sales by Application (2019-2024)
5.1.2 Global Single-target MET TKIs Sales by Application (2025-2030)
5.1.3 Global Single-target MET TKIs Sales Market Share by Application (2019-2030)
5.2 Global Single-target MET TKIs Revenue by Application (2019-2030)
5.2.1 Global Single-target MET TKIs Revenue by Application (2019-2024)
5.2.2 Global Single-target MET TKIs Revenue by Application (2025-2030)
5.2.3 Global Single-target MET TKIs Revenue Market Share by Application (2019-2030)
5.3 Global Single-target MET TKIs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Single-target MET TKIs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Single-target MET TKIs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 WuXi STA
6.3.1 WuXi STA Company Information
6.3.2 WuXi STA Description and Business Overview
6.3.3 WuXi STA Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 WuXi STA Single-target MET TKIs Product Portfolio
6.3.5 WuXi STA Recent Developments/Updates
6.4 Shanghai Hutchison Pharmaceuticals
6.4.1 Shanghai Hutchison Pharmaceuticals Company Information
6.4.2 Shanghai Hutchison Pharmaceuticals Description and Business Overview
6.4.3 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio
6.4.5 Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
6.5 Haihe Biopharma
6.5.1 Haihe Biopharma Company Information
6.5.2 Haihe Biopharma Description and Business Overview
6.5.3 Haihe Biopharma Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Haihe Biopharma Single-target MET TKIs Product Portfolio
6.5.5 Haihe Biopharma Recent Developments/Updates
6.6 CSPC Pharmaceutical
6.6.1 CSPC Pharmaceutical Company Information
6.6.2 CSPC Pharmaceutical Description and Business Overview
6.6.3 CSPC Pharmaceutical Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSPC Pharmaceutical Single-target MET TKIs Product Portfolio
6.6.5 CSPC Pharmaceutical Recent Developments/Updates
6.7 Avistone Pharmaceuticals Biotechnology
6.7.1 Avistone Pharmaceuticals Biotechnology Company Information
6.7.2 Avistone Pharmaceuticals Biotechnology Description and Business Overview
6.7.3 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio
6.7.5 Avistone Pharmaceuticals Biotechnology Recent Developments/Updates
6.8 Asymchem
6.8.1 Asymchem Company Information
6.8.2 Asymchem Description and Business Overview
6.8.3 Asymchem Single-target MET TKIs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Asymchem Single-target MET TKIs Product Portfolio
6.8.5 Asymchem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Single-target MET TKIs Industry Chain Analysis
7.2 Single-target MET TKIs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Single-target MET TKIs Production Mode & Process
7.4 Single-target MET TKIs Sales and Marketing
7.4.1 Single-target MET TKIs Sales Channels
7.4.2 Single-target MET TKIs Distributors
7.5 Single-target MET TKIs Customers
8 Single-target MET TKIs Market Dynamics
8.1 Single-target MET TKIs Industry Trends
8.2 Single-target MET TKIs Market Drivers
8.3 Single-target MET TKIs Market Challenges
8.4 Single-target MET TKIs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Single-target MET TKIs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Single-target MET TKIs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Single-target MET TKIs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Single-target MET TKIs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Single-target MET TKIs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Single-target MET TKIs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Single-target MET TKIs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Single-target MET TKIs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Single-target MET TKIs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Single-target MET TKIs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Single-target MET TKIs, Product Type & Application
 Table 12. Global Key Manufacturers of Single-target MET TKIs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Single-target MET TKIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single-target MET TKIs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Single-target MET TKIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Single-target MET TKIs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Single-target MET TKIs Sales Market Share by Region (2019-2024)
 Table 19. Global Single-target MET TKIs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Single-target MET TKIs Sales Market Share by Region (2025-2030)
 Table 21. Global Single-target MET TKIs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Single-target MET TKIs Revenue Market Share by Region (2019-2024)
 Table 23. Global Single-target MET TKIs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Single-target MET TKIs Revenue Market Share by Region (2025-2030)
 Table 25. North America Single-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Single-target MET TKIs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Single-target MET TKIs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Single-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Single-target MET TKIs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Single-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Single-target MET TKIs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Single-target MET TKIs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Single-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Single-target MET TKIs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Single-target MET TKIs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Single-target MET TKIs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Single-target MET TKIs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Single-target MET TKIs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Single-target MET TKIs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Single-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Single-target MET TKIs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Single-target MET TKIs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Single-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Single-target MET TKIs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Single-target MET TKIs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Single-target MET TKIs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Single-target MET TKIs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Single-target MET TKIs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Single-target MET TKIs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Single-target MET TKIs Sales (K Units) by Type (2019-2024)
 Table 51. Global Single-target MET TKIs Sales (K Units) by Type (2025-2030)
 Table 52. Global Single-target MET TKIs Sales Market Share by Type (2019-2024)
 Table 53. Global Single-target MET TKIs Sales Market Share by Type (2025-2030)
 Table 54. Global Single-target MET TKIs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Single-target MET TKIs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Single-target MET TKIs Revenue Market Share by Type (2019-2024)
 Table 57. Global Single-target MET TKIs Revenue Market Share by Type (2025-2030)
 Table 58. Global Single-target MET TKIs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Single-target MET TKIs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Single-target MET TKIs Sales (K Units) by Application (2019-2024)
 Table 61. Global Single-target MET TKIs Sales (K Units) by Application (2025-2030)
 Table 62. Global Single-target MET TKIs Sales Market Share by Application (2019-2024)
 Table 63. Global Single-target MET TKIs Sales Market Share by Application (2025-2030)
 Table 64. Global Single-target MET TKIs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Single-target MET TKIs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Single-target MET TKIs Revenue Market Share by Application (2019-2024)
 Table 67. Global Single-target MET TKIs Revenue Market Share by Application (2025-2030)
 Table 68. Global Single-target MET TKIs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Single-target MET TKIs Price (US$/Unit) by Application (2025-2030)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Novartis Single-target MET TKIs Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Merck Single-target MET TKIs Product
 Table 79. Merck Recent Developments/Updates
 Table 80. WuXi STA Company Information
 Table 81. WuXi STA Description and Business Overview
 Table 82. WuXi STA Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. WuXi STA Single-target MET TKIs Product
 Table 84. WuXi STA Recent Developments/Updates
 Table 85. Shanghai Hutchison Pharmaceuticals Company Information
 Table 86. Shanghai Hutchison Pharmaceuticals Description and Business Overview
 Table 87. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product
 Table 89. Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
 Table 90. Haihe Biopharma Company Information
 Table 91. Haihe Biopharma Description and Business Overview
 Table 92. Haihe Biopharma Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Haihe Biopharma Single-target MET TKIs Product
 Table 94. Haihe Biopharma Recent Developments/Updates
 Table 95. CSPC Pharmaceutical Company Information
 Table 96. CSPC Pharmaceutical Description and Business Overview
 Table 97. CSPC Pharmaceutical Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. CSPC Pharmaceutical Single-target MET TKIs Product
 Table 99. CSPC Pharmaceutical Recent Developments/Updates
 Table 100. Avistone Pharmaceuticals Biotechnology Company Information
 Table 101. Avistone Pharmaceuticals Biotechnology Description and Business Overview
 Table 102. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product
 Table 104. Avistone Pharmaceuticals Biotechnology Recent Developments/Updates
 Table 105. Asymchem Company Information
 Table 106. Asymchem Description and Business Overview
 Table 107. Asymchem Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Asymchem Single-target MET TKIs Product
 Table 109. Asymchem Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Single-target MET TKIs Distributors List
 Table 113. Single-target MET TKIs Customers List
 Table 114. Single-target MET TKIs Market Trends
 Table 115. Single-target MET TKIs Market Drivers
 Table 116. Single-target MET TKIs Market Challenges
 Table 117. Single-target MET TKIs Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Single-target MET TKIs
 Figure 2. Global Single-target MET TKIs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Single-target MET TKIs Market Share by Type: 2023 & 2030
 Figure 4. Capmatinib Product Picture
 Figure 5. Tepotinib Product Picture
 Figure 6. Savolitinib Product Picture
 Figure 7. Glumetinib Product Picture
 Figure 8. Vebreltinib Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Single-target MET TKIs Market Value by Application (2024-2030) & (US$ Million)
 Figure 11. Global Single-target MET TKIs Market Share by Application: 2023 & 2030
 Figure 12. Hospital and Clinic
 Figure 13. Retail Pharmacies
 Figure 14. Other
 Figure 15. Global Single-target MET TKIs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Single-target MET TKIs Market Size (2019-2030) & (US$ Million)
 Figure 17. Global Single-target MET TKIs Sales (2019-2030) & (K Units)
 Figure 18. Global Single-target MET TKIs Average Price (US$/Unit) & (2019-2030)
 Figure 19. Single-target MET TKIs Report Years Considered
 Figure 20. Single-target MET TKIs Sales Share by Manufacturers in 2023
 Figure 21. Global Single-target MET TKIs Revenue Share by Manufacturers in 2023
 Figure 22. Global 5 and 10 Largest Single-target MET TKIs Players: Market Share by Revenue in Single-target MET TKIs in 2023
 Figure 23. Single-target MET TKIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 24. Global Single-target MET TKIs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 25. North America Single-target MET TKIs Sales Market Share by Country (2019-2030)
 Figure 26. North America Single-target MET TKIs Revenue Market Share by Country (2019-2030)
 Figure 27. United States Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Canada Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Europe Single-target MET TKIs Sales Market Share by Country (2019-2030)
 Figure 30. Europe Single-target MET TKIs Revenue Market Share by Country (2019-2030)
 Figure 31. Germany Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. France Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. U.K. Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Italy Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Russia Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Asia Pacific Single-target MET TKIs Sales Market Share by Region (2019-2030)
 Figure 37. Asia Pacific Single-target MET TKIs Revenue Market Share by Region (2019-2030)
 Figure 38. China Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Japan Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. South Korea Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. India Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Australia Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. China Taiwan Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Southeast Asia Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Latin America Single-target MET TKIs Sales Market Share by Country (2019-2030)
 Figure 46. Mexico Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Brazil Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Argentina Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Colombia Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Middle East and Africa Single-target MET TKIs Sales Market Share by Country (2019-2030)
 Figure 51. Middle East and Africa Single-target MET TKIs Revenue Market Share by Country (2019-2030)
 Figure 52. Turkey Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Saudi Arabia Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. UAE Single-target MET TKIs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Global Sales Market Share of Single-target MET TKIs by Type (2019-2030)
 Figure 56. Global Revenue Market Share of Single-target MET TKIs by Type (2019-2030)
 Figure 57. Global Single-target MET TKIs Price (US$/Unit) by Type (2019-2030)
 Figure 58. Global Sales Market Share of Single-target MET TKIs by Application (2019-2030)
 Figure 59. Global Revenue Market Share of Single-target MET TKIs by Application (2019-2030)
 Figure 60. Global Single-target MET TKIs Price (US$/Unit) by Application (2019-2030)
 Figure 61. Single-target MET TKIs Value Chain
 Figure 62. Single-target MET TKIs Production Process
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart